Pharmaceutical News

RSS

Parkinson's disease drugs may lead to impulse control disorders

Mayo Clinic researchers found that dopamine agonists used in treating Parkinson's disease result in impulse control disorders in as many as 22 percent of patients.

25 Mar 2011

Althea extends labeling, packaging of biological product services through Sherpa

Althea Technologies, Inc. announced today that it has extended its service offering to include labeling, packaging, storage and distribution of drug and biological products through its co-marketing partner, Sherpa Clinical Packaging.

25 Mar 2011

New findings may make morphine a safer, more effective drug for chronic pain control

An orphan drug originally used for HIV treatment has been found to short-circuit the process that results in additional sensitivity and pain from opioid use. The study by researchers at the Indiana University School of Medicine is reported in the March 25, 2011 issue of Brain, Behavior and Immunity.

25 Mar 2011

Dabigatran etexilate is less costly, more effective for stroke treatment in patients with AF

A new economic analysis, published online in Thrombosis and Haemostasis, suggested that Boehringer Ingelheim's novel oral direct thrombin inhibitor dabigatran etexilate is cost-effective compared to current treatment options, particularly in real-world clinical practice.

25 Mar 2011

Columbia University, Sanofi-aventis collaborate to develop innovative diabetes medicines

Sanofi-aventis announced today a research collaboration with Columbia University Medical Center for the development of innovative diabetes medicines.

25 Mar 2011

USPTO issues Notice of Allowance to AlphaRx ARX8203 pain product candidate

AlphaRx Inc. has received a Notice of Allowance from the United States Patent and Trademark Office for its lead pain product candidate code named ARX8203, a potentially safer drug intended for pain treatment.

25 Mar 2011

AACP selects Maryland professor for Pharmacy Educator Award

The American Association of Colleges of Pharmacy has selected innovative educator and mentor Robert Beardsley, RPh, PhD, MS, to receive the group's prestigious 2011 Robert K. Chalmers Distinguished Pharmacy Educator Award.

25 Mar 2011

Agilent opens new lab facility in Bangalore, India

Agilent Technologies Inc. has expanded its Life Sciences and Chemical Analysis Center of Excellence in Bangalore.

25 Mar 2011

Researchers identify gene that can predict hypersensitivity to epilepsy drug

Research published this week in the New England Journal of Medicine. A multinational team of scientists led by the Royal College of Surgeons in Ireland and the University of Liverpool has identified a gene that could indicate if epilepsy patients starting a common drug treatment are likely to experience side-effects ranging from a mild skin irritation to the potentially fatal Steven-Johnson Syndrome.

25 Mar 2011

APC-300 drug significantly inhibits pancreatic cancer cell growth: Adamis

Adamis Pharmaceuticals Corporation announced today that in addition to its activity in prostate cancer, its drug APC-300 significantly inhibits the growth of pancreatic cancer cells.

25 Mar 2011

Sitagliptin drug can slow onset of diabetes

Diabetes type 2 is caused by insufficient levels of insulin to keep blood glucose under control. Excessive levels of another hormone, glucagon, can also contribute to diabetes type 2 by causing the liver to flood the body with stored glucose.

25 Mar 2011

Merck & Co receives FDA approval for Zostavax vaccine to treat shingles

The Food and Drug Administration today approved the use of Zostavax, a live attenuated virus vaccine, for the prevention of shingles in individuals 50 to 59 years of age. Zostavax is already approved for use in individuals 60 years of age and older.

25 Mar 2011

Perceptive Informatics announces eClinical Product Suite survey results

Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation, today announced results of a survey conducted during its recent webinar entitled "Designing and Delivering an eClinical Product Suite."

From Parexel 24 Mar 2011

Pharmacists seek delay of rule limiting amount of dispensed drugs

The National Community Pharmacists Association is pressuring Medicare officials to delay a regulation that they say will drive up labor costs for drug stores and increase the potential for dispensing errors. The proposed rule is expected to be finalized and take effect on Jan. 1, 2012.

24 Mar 2011

ASAM issues white paper to halt medical marijuana use

Citing the dangers of marijuana, the lack of clinical research on a controlled substance with a high potential for abuse, and the physician's oath to "first, do no harm," the American Society of Addiction Medicine today issued a white paper recommending a halt to using the weed as a medicine in states where it has been declared legal.

24 Mar 2011

Colorcon announces specific details on its patent positions for enteric coatings

Colorcon, Inc., a wholly owned subsidiary of BPSI Holdings Inc., today announced specific details on its world-wide patent positions for enteric coating compositions in response to misleading statements made in the international press, particularly in India.

24 Mar 2011

Star Scientific's Ariva-BDL and Stonewall-BDL modified risk tobacco products not subject to FDC Act Chapter IX

Star Scientific, Inc. announced that the company has received notices from the Food and Drug Administration (FDA) regarding its pending ARIVA-BDL™ and STONEWALL-BDL™ modified risk tobacco product applications.

24 Mar 2011

Prolia associated with greater adherence than alendronate in postmenopausal women with osteoporosis

Amgen today announced new data that showed postmenopausal women with osteoporosis had significantly greater adherence, compliance, and persistence during Prolia® (denosumab) treatment than during alendronate treatment, an oral bisphosphonate commonly used to treat osteoporosis.

24 Mar 2011

WHO report urges countries to step up fight against drug-resistant TB

A WHO report released Wednesday says countries with the highest drug-resistant tuberculosis burdens are making progress in addressing the disease, "but despite the recent scale up in efforts, the world needs to do much more to get care to all [multi-drug resistant] patients who need it," WHO Director-General Margaret Chan said, Times LIVE reports.

24 Mar 2011

Resveratrol can provide resistance before and after hazardous radiation exposure

Clinical studies of Resveratrol--recognized for its proven role in activating the longevity gene to inhibit age-related diseases--have shown that its antioxidant power provides resistance before and after exposure to hazardous radiation.

24 Mar 2011

Pharmaceutical News

Parkinson's disease drugs may lead to impulse control disorders

Althea extends labeling, packaging of biological product services through Sherpa

New findings may make morphine a safer, more effective drug for chronic pain control

Dabigatran etexilate is less costly, more effective for stroke treatment in patients with AF

Columbia University, Sanofi-aventis collaborate to develop innovative diabetes medicines

USPTO issues Notice of Allowance to AlphaRx ARX8203 pain product candidate

AACP selects Maryland professor for Pharmacy Educator Award

Agilent opens new lab facility in Bangalore, India

Researchers identify gene that can predict hypersensitivity to epilepsy drug

APC-300 drug significantly inhibits pancreatic cancer cell growth: Adamis

Sitagliptin drug can slow onset of diabetes

Merck & Co receives FDA approval for Zostavax vaccine to treat shingles

Perceptive Informatics announces eClinical Product Suite survey results

Pharmacists seek delay of rule limiting amount of dispensed drugs

ASAM issues white paper to halt medical marijuana use

Colorcon announces specific details on its patent positions for enteric coatings

Star Scientific's Ariva-BDL and Stonewall-BDL modified risk tobacco products not subject to FDC Act Chapter IX

Prolia associated with greater adherence than alendronate in postmenopausal women with osteoporosis

WHO report urges countries to step up fight against drug-resistant TB

Resveratrol can provide resistance before and after hazardous radiation exposure

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News